- Home
- PKOH vs CRVS Comparison
PKOH vs CRVS Comparison
Compare PKOH & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKOH
- CRVS
- Stock Information
- Founded
- PKOH 1907
- CRVS 2014
- Country
- PKOH United States
- CRVS United States
- Employees
- PKOH N/A
- CRVS N/A
- Industry
- PKOH Industrial Specialties
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- PKOH Industrials
- CRVS Health Care
- Exchange
- PKOH Nasdaq
- CRVS Nasdaq
- Market Cap
- PKOH 282.2M
- CRVS 328.5M
- IPO Year
- PKOH N/A
- CRVS 2016
- Fundamental
- Price
- PKOH $17.54
- CRVS $4.04
- Analyst Decision
- PKOH
- CRVS Strong Buy
- Analyst Count
- PKOH 0
- CRVS 4
- Target Price
- PKOH N/A
- CRVS $15.00
- AVG Volume (30 Days)
- PKOH 28.3K
- CRVS 820.4K
- Earning Date
- PKOH 08-06-2025
- CRVS 08-05-2025
- Dividend Yield
- PKOH 2.81%
- CRVS N/A
- EPS Growth
- PKOH 144.68
- CRVS N/A
- EPS
- PKOH 2.26
- CRVS N/A
- Revenue
- PKOH $1,644,000,000.00
- CRVS N/A
- Revenue This Year
- PKOH $1.80
- CRVS N/A
- Revenue Next Year
- PKOH $3.97
- CRVS N/A
- P/E Ratio
- PKOH $7.90
- CRVS N/A
- Revenue Growth
- PKOH N/A
- CRVS N/A
- 52 Week Low
- PKOH $16.81
- CRVS $1.75
- 52 Week High
- PKOH $34.50
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- PKOH 46.28
- CRVS 54.66
- Support Level
- PKOH $16.81
- CRVS $3.55
- Resistance Level
- PKOH $18.37
- CRVS $4.33
- Average True Range (ATR)
- PKOH 0.62
- CRVS 0.29
- MACD
- PKOH 0.06
- CRVS -0.01
- Stochastic Oscillator
- PKOH 52.33
- CRVS 57.94
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).